Can a food and friendship program slow kidney disease?
NCT ID NCT05970341
First seen Sep 21, 2026 · Last updated Sep 21, 2026
Summary
Researchers at the University of Texas at Austin are testing a 6-month community program for low-income adults with early chronic kidney disease. Participants receive kidney-friendly recipes, educational materials, and regular check-ins from a health partner. The trial compares this program with educational materials and usual care alone, measuring changes in kidney damage, blood sugar, blood pressure, mood, and diet quality.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a 6-month community-based nutrition and health-partner support program
- What this could lead to
- If it works, this could give clinics a low-cost, community-based way to slow early kidney disease and lower heart risk through diet and support.
- What could go wrong
- The program may not change kidney or heart markers more than usual care, and results in low-income primary care patients may not apply to other groups. Diet and lifestyle programs often show small effects that fade without ongoing support.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 330 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult (18 years of age or older) * Primary care visit at either one of the three partner clinics from Harris Health \[Smith Clinic, Harris Health Outpatient Center (located on the LBJ campus), or Martin Luther King Jr. Health Center (MLK)\] and a primary care patient within Harris Health System * Have had at least 1 visit in the past 18 months with prior history in the clinic (i.e., not first visit) * Diagnosis of CKD (Stage 2, 3a, and 3b) as defined by estimated Glomerular Filtration Rate (eGFR) ≥ 30 and \<90 mL/min/1.73 m2 OR CDK 1 or undiagnosed with urine Albumin Creatinine Ratio ≥ 30 mg/g * Within the past 12 months, the most current serum K+ ≤ 4.6 mEq/L * English or Spanish speaking * Ability to participate in the program at least 6 months * Ability to clean, prepare, refrigerate/freeze food products that are given to them * Have access to receive SMS text messages * Location of preferred produce bag delivery within an available delivery zone Exclusion Criteria: * CKD 4, ESRD or on dialysis. * Taking certain medications chronically (more than twice a week for 90 days) that may interfere with K+ metabolism (such as non-steroidal anti-inflammatory drugs (NSAIDs), as self-reported during enrollment screening * Taking mineralocorticoid receptor antagonists * Taking Warfarin * Diagnosis of any specific kidney conditions (such as polycystic kidney disease, glomerulonephritis, Lupus associated with Nephritis, Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)) that would contraindicate study participation as determined by physician * Medical history of organ transplant that would contraindicate study participation as determined by physician * Received immunotherapy for primary or secondary kidney disease within 6 months prior to enrolment * Diagnostic of heart failure conditions Class IV in the New York Heart Association (NYHA) functional classification * Had myocardial infarction, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks prior to enrolment * Had coronary revascularization (PCI, CABG) or valvular repair within 12 weeks prior to enrolment * On active hospice care as self-reported during enrollment screening * Diagnosis of active malignancy requiring treatment that would contraindicate study participation as determined by physician * Has decompensated cirrhosis as determined by physician * Cognitive impairment that would contraindicate study participation as self-reported during enrollment screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harris Health System's Martin Luther King Jr. Health Center
Houston, Texas, 77047, United States
-
Harris Health System's Outpatient Center
Houston, Texas, 77026, United States
-
Harris Health System's Smith Clinic
Houston, Texas, 77054, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Does better dialysis keep parathyroid hormone in check?
- Biobank aims to unlock the mysteries of calciphylaxis
- Do kidney patients know why a fistula matters before dialysis?
- Potassium binder may let kidney patients keep Life-Saving heart drugs